Postoperative Infection of the Spine: Management and Outcomes at a Single Institution. A Retrospective Study
© 2024 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Wounds or HMP Global, their employees, and affiliates.
Abstract
Background. Surgical site infection (SSI) is a potential complication of spine surgery and a significant cause of readmission and surgical revision. Furthermore, the presence of comorbidities, along with the rising frequency of spinal surgeries, may result in secondary infections, thereby elevating the risk of these infections and affecting overall health. Objective. To assess the study authors’ approach for preventing and managing postoperative infections in their center and identify the spine surgeries most susceptible to infection. Materials and Methods. The authors conducted a retrospective study of 2559 patients at a single clinical center who underwent various lumbar spine surgeries, including interlaminar device plus diskectomy, diskectomy, interlaminar device plus recalibration, unilateral recalibration, and bilateral recalibration, among others, between March 1, 2015, and March 31, 2023. Results. Of these 2559 patients, 54 (2.11%) were readmitted due to infection and underwent reoperation. The most common isolated microorganism was Staphylococcus aureus. Infection occurred in 1.9% of instrumentation surgeries and 2.3% of non-instrumentation surgeries; this difference was not statistically significant. Infected patients received empiric dual antibiotic therapy after sampling of the surgical site and before identification of the causative organisms. Conclusion. The results of this study indicate that comorbidities increase the risk of infection. However, the authors did not find that instrumentation in spinal surgery escalates this risk. Empiric dual antibiotic therapy was effective in managing SSI prior to identification of the microorganisms via culture.
Abbreviations: ASA, American Society of Anesthesiologists Physical Status classification; ICD-9, International Classification of Diseases, Ninth Revision; IRB, institutional review board; IV, intravenous; SSI, surgical site infection.
Background
SSI is one of the most important complications of spinal surgery in terms of clinical outcomes and patients’ health status.1 It is a major reason for readmission after lumbar spine surgery.2-5 The infection rate after lumbar spine surgery has been reported to range from 1% to 9%.6-12 The rate of infection after instrumented spine surgery ranges from 0.7% to 12%.2-17 Factors that increase the risk of SSI developing include type and duration of surgery, as well as several comorbidities: diabetes, smoking, obesity, malnutrition, and poor general condition.7-18 Risks of infection depend not only on the factors mentioned above, but also on perioperative and postoperative conditions.2-5,8,12-15,19-23 Failure of the operating room ventilation system, the length of the surgery, staff coming and going in the operating room, postoperative dressings protocols, and scar length have been identified as risks for infection.3-5,7-11,15-18,23,24
This retrospective observational study aimed to collect and analyze data on the incidence of postoperative SSI following a consecutive series of spine operations to evaluate the associated risk factors for such infections.
Materials and Methods
Study population and setting
Between March 2015 and March 2023, a total of 2559 patients underwent surgery for degenerative diseases, spine tumors, and traumatic spine injuries at a single clinical center. All patients provided informed consent for their surgeries.
Outcome definition
The diagnosis of SSI was made between the fourth and 30th postoperative days. SSI was defined using ICD-9 codes and clinical criteria, including elevated white blood cell count, high C-reactive protein levels, and signs of infection such as pain, fever, chills, tenderness, wound dehiscence, redness, swelling, and purulent discharge (Figure).
Predictor variables
The ASA score was used to assess perioperative risks and the risk of SSI. Standard institutional antibiotic prophylaxis was administered to all patients, with an enhanced protocol introduced in March 2019.
Ethical considerations
This was an observational study. The Research Ethics Committee of the Clinical Centre in Soyaux, France, confirmed that no ethical approval was required from an IRB and that written consent from participants was not necessary.
Statistical analysis
Data were analyzed using SPSS version 22 (IBM Corporation). Analysis of variance testing with the Tukey honestly significant difference as the post hoc test was used to compare infection ratios across different surgical and ASA score groups.
To ensure objectivity throughout the analysis, patient names and identifying information were kept confidential. No biases or conflicts arose during surgeries, data collection, or outcome analysis. This study adhered to a double-masked review process as per the IRB guidelines, in which the identities of the authors were concealed from the IRB members and the authors remained unaware of the IRB members’ identities.
Results
Patient characteristics
Out of 2559 operated patients, 54 (2.11%) required readmission due to infections; all 54 patients underwent reoperation. The majority of infections were caused by gram-positive bacteria, with Staphylococcus aureus being the most frequent bacterium (56.82%). The most common isolated microorganisms were gram-positive bacteria, with S. aureus being the most frequent bacterium, in 31 of the 54 cases (56.82%). The next most common organism was Staphylococcus epidermidis, in 13 cases (24.1%). In 12 cases (22.2%), 2 or more bacteria were identified. Table 1 presents the isolated microorganisms.
All of the operated patients underwent revision surgery with the aim of obtaining sampling for bacteriological detection of microorganisms and cleaning the surgical site. Among the infected patients, 28 had undergone instrumentation surgery for the first procedure, while 26 had undergone surgery without instrumentation (Table 2). The infection rate was 1.9% for instrumentation surgery and 2.3% for non-instrumentation surgery, which was a nonsignificant difference. Among the 28 infected patients who had previously undergone instrumentation surgery, 10 had the material removed and 18 had the material left in place.
Predictor analysis
The risk of SSI increased with rising ASA score. The infection rates were 0.78% for ASA I, 2.22% for ASA II, and 2.88% for ASA III patients (Table 3). The difference between ASA I with ASA II and ASA III were statistically significant (P > .001). The likelihood of SSI escalated in correlation with an increasing ASA score. Infection rates were recorded at 0.78% for patients classified as ASA I, 2.22% for those categorized as ASA II, and 2.88% for ASA III patients (Table 3). The disparities observed between ASA I and both ASA II and ASA III were statistically significant. Therefore, it can be concluded that a higher ASA score corresponds to an elevated risk of infection.
Discussion
Importance of ASA score and type of surgery in infection
Analysis of these data suggests that the risk of SSI increases with rising ASA score. As noted above, the SSI rate was less than 1% (0.78%) in ASA I patients and was 2.22% in ASA II patients. The rate rose to 2.88% in ASA III patients (Table 3). The ASA score could be considered a pivotal factor in identifying patients at high risk for SSI. This finding suggests that more stringent preventive care should be implemented for these patients postoperatively. These findings are statistically significant and are consistent with the literature.25-27
The highest number of infections was observed in patients who had interlaminar devices plus diskectomies (12 cases), followed by interlaminar devices plus recalibrations (11 cases), bilateral recalibrations without instrumentation (9 cases), and unilateral recalibrations without instrumentation (8 cases) (Table 2). However, statistical analysis shows a lower infection percentage in patients operated on with interlaminar devices plus diskectomies (1.54%) and interlaminar devices plus recalibrations (1.93%). The highest infection percentage was observed in patients operated on with lumbar interbody cages (7 cases, with 1 infection [14.29%]), followed by posterior osteosynthesis plus interbody cages (19 cases, with 2 infections [10.53%]). The infection rate varied markedly among different surgical groups, with the exception of oblique lateral interbody fusion, transforaminal lumbar interbody fusion, anterior lumbar interbody fusion, and surgeries for lumbar or thoracic spine tumors, where the ratio was 0 and the sample size was small. The low case numbers in these groups may introduce bias in the percentage calculation. Among the 1128 patients operated on without instrumentation, there were 26 infections (2.30%). Among the 1431 patients operated on with instrumentation, 28 patients had infection (1.96%). There were no significant differences between the 2 groups. However, many studies show that spinal instrumentation is associated with an increased rate of SSI.5,10,28-30
Pull ter Gunne and Cohen5 reported an SSI rate of 1% in spine surgery without instrumentation and 9% with instrumentation. Gerometta et al reported a 1% SSI rate after simple diskectomy, increasing to 2% to 5% when there is a posterior spinal fusion.30 Di Martino et al reported an SSI incidence ranging from 0.26% to 2.75% for spinal surgery without instrumentation and 2.1% to 8.5% for instrumented surgery.39 Reoperated patients were followed for 1 year postoperatively and were evaluated at 1 month, 3 months, 6 months, and 1 year. There were no cases of relapse or discitis.
Microorganisms and antibiotic therapy
As soon as patients were operated on and samples were obtained, empiric antibiotic therapy was initiated for coverage of staphylococci, streptococci, enterococci, and gram-negative bacilli. In the first 34 cases, after sampling the patient received empiric dual antibiotic therapy consisting of gentamicin 1.5 mg/kg/12 hours plus vancomycin 15 mg/kg/12 hours. For the last 20 patients, this dual therapy consisted of piperacillin-tazobactam 4 g/8 hours and linezolid 600 mg/12 hours. Linezolid is a relatively new synthetic antibiotic with an effect on methicillin-resistant S. aureus.32 The authors of the current study found no specific advice on the use of linezolid in the literature, but its addition to piperacillin-tazobactam was effective and showed a reduction in C-reactive protein and other inflammatory signs. The use of linezolid has been reported in the literature without any real efficacy.32-34 As soon as the antibiogram has been performed, the patient should receive empiric dual antibiotic therapy for 6 weeks. In the immediate postoperative period, the patient should undergo blood tests twice a week, a cardiac ultrasound, and lumbar imaging (ie, magnetic resonance imaging or, if that is contraindicated, computed tomography). Thereafter, biological monitoring should be performed weekly. However, Palmowski et al35 recommend antibiotic therapy for 10 weeks. If the implant needs to be retained, a 2-week course of IV antibiotic treatment should be followed by 10 weeks of oral antibiotic therapy.
Dowdell et al36 recommended antibiotic therapy for 3 months or more in cases of postoperative discitis/osteomyelitis. Kowalski et al37 recommended treatment for 4 to 6 weeks. However, Clark and Shufflebarger41 reported successfully treating SSI with a 3-day IV course of antibiotics and 7 days of oral antibiotics, which resulted in complete resolution of infection. The authors of the current study have not found a precise protocol for empiric antibiotic therapy, but all the authors believe that IV antibiotics should be maintained until culture is obtained and that culture should begin after the debridement if the patient’s condition is stable. In the septic patient, broad-spectrum antibiotics should be started even before sampling.2-8,10,12-18,20,21,28-31,35-41
As noted above, S. epidermidis was the second most commonly identified organism in the present study, with 13 cases (19.12%), followed by Enterococcus faecium and Escherichia coli in 4 cases each (5.88%). In 53 cases (77.94%), the microorganisms found were gram-positive cocci. In 15 cases (22.06%), bacilli were responsible for the infection. The denominator represents the total count of identified germs, as there were instances where multiple germs were detected in a single patient. This indicates that the total number of germs exceeds the number of infected patients. Abdul-Jabbar et al42 found similar results, with S. aureus isolated in 45.2% and S. epidermidis isolated in 31.4% of 239 cases of SSI. Kobayashi et al43 reported similar results, as well.
Kobayashi et al43 highlighted the climatic factor in infection, noting an SSI rate of 2.6% in the spring, 3.9% in summer, 1.3% in fall, and 1.8% in winter out of a total of 1174 patients. Durkin et al44 also reported a significant worsening in the summer; notably, the rates of SSI due to gram-positive cocci and S. aureus were higher in summer. Analysis of the data in the present study does not confirm these findings: there were 13 infections in the spring (24.07%), 13 in summer (24.07%), 13 in fall (24.07%), and 15 in winter (27.78%). There were no yeast infections.
Several studies note the importance of prevention. Tomov et al45 recommended application of intra-wound vancomycin powder, wound irrigation with dilute betadine solution, preoperative chlorhexidine gluconate scrubs, preoperative screening with nasal swabbing, and decolonization of S. aureus, as well as perioperative antibiotic administration. They reported an average 2% decrease in infection with these measures during the study period (2006-2016).45 Meza et al17 reported a decrease in infection from 1.70% to 0.20% after betadine irrigation and intrawound vancomycin powder before closure became standard treatment.
The lower back is a site of friction, characterized by thick skin and poor vascular perfusion. The feelings and experiences of the authors of the present manuscript led the authors to believe that these anatomic particularities may contribute to the onset of infection. However, there are no studies that discuss this.
Limitations
This study has several limitations. Firstly, the small sample size for certain surgery types may affect the generalizability of the findings. Secondly, the research was conducted at a single center, which could limit the applicability of the results to other settings. Additionally, it was necessary to change the antibiotic regimen during management due to nonresponsiveness in some cases. Moreover, the timing of debridement was not precisely documented, and there is a lack of long-term follow-up data for the patients included in the study. These factors may affect the overall interpretation and robustness of the outcomes.
Conclusion
The current study aligns with other research regarding the microorganisms most commonly involved in SSIs. The authors’ protocol for managing SSI using empiric antibiotic therapy prior to organism identification proved to be effective. The ASA score can be a crucial indicator for identifying patients at high risk for SSI. Therefore, more rigorous preventive measures should be applied to these patients after surgery. Notably, no significant difference was found in infection rates between surgeries without instrumentation and those with instrumentation. This finding contrasts with the majority of the literature, which typically reports higher SSI rates following instrumentation. However, the results of this study were more favorable, indicating a lower infection rate in such cases.
Author & Publication Information
Authors: Keyvan Mostofi, MD, PhD1; Kamran Shirbache, MD2; and Gianluca Caragliano, MD3
Affiliations: 1Department of Neurosurgery, Centre Clinical, Soyaux, France; 2Department of Orthopedics, Robert-Debré AP-HP Hospital, Paris, France; 3Department of Anesthesiology, Centre Clinical, Soyaux, France
ORCID: Caragliano, 0009-0006-0714-4893; Mostofi, 0000-0002-9106-2359; Shirbache, 0000-0002-9042-9534
Disclosure: The authors disclose no financial or other conflicts of interest.
Ethical Approval: Informed consent was obtained from all study participants. The Research Ethics Committee of the Clinical Centre in Soyaux has confirmed that no ethical approval is required to/from an institutional review board.
Correspondence: Keyvan Mostofi, MD; Department of Neurosurgery, Clinical Centre, Soyaux, France; keyvan.mostofi@elsan.care
Manuscript Accepted: August 21, 2024
References
1. Broumand F, Vakili NZ, Yekta Z, Vazifekhah S. Comparative study of surgical site infection with or without post cesarean prophylactic oral antibiotics; a single-blinded randomized clinical trial. J Prev Epidemiol. 2022;7(1):e07. doi:10.34172/jpe.2022.07
2. Snopko P, Kolarovszki B, Opšenák R, Hanko M, Richterová R. Surgical site infections after degenerative lumbar spine surgery. Rozhl Chir. 2018;97(12):539-545.
3. Schimmel JJ, Horsting PP, de Kleuver M, Wonders G, van Limbeek J. Risk factors for deep surgical site infections after spinal fusion. Eur Spine J. 2010;19(10):1711-1719. doi:10.1007/s00586-010-1421-y
4. Cizik AM, Lee MJ, Martin BI, et al. Using the spine surgical invasiveness index to identify risk of surgical site infection: a multivariate analysis. J Bone Joint Surg Am. 2012;94(4):335-342. doi:10.2106/JBJS.J.01084
5. Pull ter Gunne AF, Cohen DB. Incidence, prevalence, and analysis of risk factors for surgical site infection following adult spinal surgery. Spine (Phila Pa 1976). 2009;34(13):1422-1428. doi:10.1097/BRS.0b013e3181a03013
6. Tan T, Lee H, Huang MS, et al. Prophylactic postoperative measures to minimize surgical site infections in spine surgery: systematic review and evidence summary. Spine J. 2020;20(3):435-447. doi:10.1016/j.spinee.2019.09.01
7. Ying H, Luo ZW, Peng AF, et al. Incidences and reasons of postoperative surgical site infection after lumbar spinal surgery: a large population study. Eur Spine J. 2022;31(2):482-488. doi:10.1007/s00586-021-06967-1
8. Anderson PA, Savage JW, Vaccaro AR, et al. Prevention of surgical site infection in spine surgery. Neurosurgery. 2017;80(3S):S114-S123. doi:10.1093/neuros/nyw066
9. Zhang X, Liu P, You J. Risk factors for surgical site infection following spinal surgery: a meta-analysis. Medicine (Baltimore). 2022;101(8):e28836. doi:10.1097/MD.0000000000028836
10. Ojo OA, Owolabi BS, Oseni AW, Kanu OO, Bankole OB. Surgical site infection in posterior spine surgery. Niger J Clin Pract. 2016;19(6):821-826. doi:10.4103/1119-3077.183237
11. Duarte RM, Vaccaro AR. Spinal infection: state of the art and management algorithm. Eur Spine J. 2013;22(12):2787-2799. doi:10.1007/s00586-013-2850-1
12. Weckbach S, Lutz B, Wölfle-Roos JV, Reichel H. Infektionen der wirbelsäule: therapiestrategien. Infections of the spine: therapeutic strategies. Chirurg. 2016;87(10):839-846. doi:10.1007/s00104-016-0247-5
13. Wang P, Liu B, Rong T, Wu B. Is diabetes the risk factor for poor neurological recovery after cervical spine surgery? A review of the literature. Eur J Med Res. 2022;27(1):263. doi:10.1186/s40001-022-00879-6
14. Kalb S, Martirosyan NL, Perez-Orribo L, Kalani MY, Theodore N. Analysis of demographics, risk factors, clinical presentation, and surgical treatment modalities for the ossified posterior longitudinal ligament. Neurosurg Focus. 2011;30(3):E11. doi:10.3171/2010.12.FOCUS10265
15. Yao R, Tan T, Tee JW, Street J. Prophylaxis of surgical site infection in adult spine surgery: a systematic review. J Clin Neurosci. 2018;52:5-25. doi:10.1016/j.jocn.2018.03.023
16. Tomov M, Mitsunaga L, Durbin-Johnson B, Nallur D, Roberto R. Reducing surgical site infection in spinal surgery with betadine irrigation and intrawound vancomycin powder. Spine (Phila Pa 1976). 2015;40(7):491-499. doi:10.1097/BRS.0000000000000789
17. Meza BC, Talwar D, Flynn JM. Measures to reduce end-of-case wound contamination: the impact of intra-wound vancomycin powder and betadine irrigation on surgical site infections in posterior spinal fusion. Spine Deform. 2020;8(1):45-50. doi:10.1007/s43390-020-00033-4
18. Lemans JVC, Öner FC, Wijdicks SPJ, Ekkelenkamp MB, Vogely HC, Kruyt MC. The efficacy of intrawound vancomycin powder and povidone-iodine irrigation to prevent surgical site infections in complex instrumented spine surgery. Spine J. 2019;19(10):1648-1656. doi:10.1016/j.spinee.2019.05.592
19. Lang S, Frömming A, Walter N, et al. Is there a difference in clinical features, microbiological epidemiology and effective empiric antimicrobial therapy comparing healthcare-associated and community-acquired vertebral osteomyelitis? Antibiotics (Basel). 2021;10(11):1410. doi:10.3390/antibiotics10111410
20. Nesnídal P, Štulík J, Kryl J, Vyskočil T, Barna M. Komplikace ve spondylochirurgii: prospektivní 13leté sledování neplánovaných revizních operací páteře. Acta Chir Orthop Traumatol Cech. 2022;89(4):243-251. doi:10.55095/achot2022/040
21. Farshad M, Bauer DE, Wechsler C, Gerber C, Aichmair A. Risk factors for perioperative morbidity in spine surgeries of different complexities: a multivariate analysis of 1,009 consecutive patients. Spine J. 2018;18(9):1625-1631. doi:10.1016/j.spinee.2018.02.003
22. Hosseinpour S, Derakhshan Barjoei MM, Izadi R, Mahmudi H, Shahani T, Mousavi MS. Prevalence of nosocomial infections in Lordegan Shohada hospital from 2017 to 2022. J Prev Epidemiol. 2023;9(1):e32201. doi:10.34172/ jpe.2023.32201
23. Mostofi K, Peyravi M, Shirbacheh A, Shirbache K. A comparison between different suture techniques in lumbar spine surgery. Int Wound J. 2023;20(2):296-301. doi:10.1111/iwj.13875
24. Lange N, Stadtmüller T, Scheibel S, et al. Analysis of risk factors for perioperative complications in spine surgery. Sci Rep. 2022;12(1):14350. doi:10.1038/s41598-022-18417-z
25. Ringeval N, Decrucq F, Weyrich P, et al. Diagnostic performance of suction drainage fluid culture for acute surgical site infection after aseptic instrumented spine surgery: a retrospective analysis of 363 cases. Eur J Orthop Surg Traumatol. 2021;31(1):155-160. doi:10.1007/s00590-020-02755-7
26. Zippelius T, Bürger J, Schömig F, Putzier M, Matziolis G, Strube P. Clinical presentation and diagnosis of acute postoperative spinal implant infection (PSII). J Spine Surg. 2020;6(4):765-771. doi:10.21037/jss-20-587
27. Somani S, Capua JD, Kim JS, et al. ASA classification as a risk stratification tool in adult spinal deformity surgery: a study of 5805 patients. Global Spine J. 2017;7(8):719-726. doi:10.1177/2192568217700106
28. Yin D, Liu B, Chang Y, Gu H, Zheng X. Management of late-onset deep surgical site infection after instrumented spinal surgery. BMC Surg. 2018;18(1):121. doi:10.1186/s12893-018-0458-4
29. Núñez-Pereira S, Benavent E, Ulldemolins M, et al; Geio-Seimc Group For The Study Of Osteoarticular Infections-Spanish Society Of Infectious Diseases And Clinical Microbiology. Cutibacterium spp. infections after instrumented spine surgery have a good prognosis regardless of rifampin use: a cross-sectional study. Antibiotics (Basel). 2023;12(3):518. doi:10.3390/antibiotics12030518
30. Gerometta A, Rodriguez Olaverri JC, Bitan F. Infections in spinal instrumentation. Int Orthop. 2012;36(2):457-464. doi:10.1007/s00264-011-1426-0
31. Kasliwal MK, Tan LA, Traynelis VC. Infection with spinal instrumentation: review of pathogenesis, diagnosis, prevention, and management. Surg Neurol Int. 2013;4(Suppl 5):S392-S403. doi:10.4103/2152-7806.120783
32. Komatsu M, Takahata M, Sugawara M, et al. Penetration of linezolid into rabbit intervertebral discs and surrounding tissues. Eur Spine J. 2010;19(12):2149-2155. doi:10.1007/s00586-010-1548-x
33. Kalanjiyam GP, Shanmuganathan R, Shetty AP, Kanna RM, Thippesamy PB, Raja DC. Rare presentation of meningitis due to lumbar facetal septic abscess: a case report. JBJS Case Connect. 2022;12(2). doi:10.2106/JBJS.CC.22.00048
34. Tsitsopoulos PP, Zevgaridis D, Anagnostopoulos I, Harms J, Tsitsopoulos P. Methicillin resistant Staphylococcus aureus thoracic spondylitis late after cervical spine surgery. Hippokratia. 2009;13(1):49-51.
35. Palmowski Y, Bürger J, Kienzle A, Trampuz A. Antibiotic treatment of postoperative spinal implant infections. J Spine Surg. 2020;6(4):785-792. doi:10.21037/jss-20-456
36. Dowdell J, Brochin R, Kim J, et al. Postoperative spine infection: diagnosis and management. Global Spine J. 2018;8(4 Suppl):37S-43S. doi:10.1177/2192568217745512
37. Kowalski TJ, Berbari EF, Huddleston PM, Steckelberg JM, Mandrekar JN, Osmon DR. The management and outcome of spinal implant infections: contemporary retrospective cohort study. Clin Infect Dis. 2007;44(7):913-920. doi:10.1086/512194
38. Emori TG, Culver DH, Horan TC, et al. National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control. 1991;19(1):19-35. doi:10.1016/0196-6553(91)90157-8
39. Di Martino A, Papalia R, Albo E, Diaz L, Denaro L, Denaro V. Infection after spinal surgery and procedures. Eur Rev Med Pharmacol Sci. 2019;23(2 Suppl):173-178. doi:10.26355/eurrev_201904_17487
40. Zhou J, Wang R, Huo X, Xiong W, Kang L, Xue Y. Incidence of surgical site infection after spine surgery: a systematic review and meta-analysis. Spine (Phila Pa 1976). 2020;45(3):208-216. doi:10.1097/BRS.0000000000003218
41. Clark CE, Shufflebarger HL. Late-developing infection in instrumented idiopathic scoliosis. Spine (Phila Pa 1976). 1999;24(18):1909-1912. doi:10.1097/00007632-199909150-00008
42. Abdul-Jabbar A, Berven SH, Hu SS, et al. Surgical site infections in spine surgery: identification of microbiologic and surgical characteristics in 239 cases. Spine (Phila Pa 1976). 2013;38(22):E1425-E1431. doi:10.1097/BRS.0b013e3182a42a68
43. Kobayashi K, Ando K, Kato F, et al. Seasonal variation in incidence and causal organism of surgical site infection after PLIF/TLIF surgery: a multicenter study. J Orthop Sci. 2021;26(4):555-559. doi:10.1016/j.jos.2020.05.015
44. Durkin MJ, Dicks KV, Baker AW, et al. Postoperative infection in spine surgery: does the month matter? J Neurosurg Spine. 2015;23(1):128-134. doi:10.3171/2014.10.SPINE14559
45. Tomov M, Wanderman N, Berbari E, et al. An empiric analysis of 5 counter measures against surgical site infections following spine surgery-a pragmatic approach and review of the literature. Spine J. 2019;19(2):267-275. doi:10.1016/j.spinee.2018.05.043